Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
Spero Therapeutics (SPRO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $75.49 M
According to Spero Therapeutics's latest financial reports the company's total liabilities are $75.49 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Spero Therapeutics - Total liabilities on balance sheet (from 2016 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $75.49 M | 54.49% |
| 2022-12-31 | $48.86 M | -40.97% |
| 2021-12-31 | $82.78 M | 286.64% |
| 2020-12-31 | $21.41 M | -32.09% |
| 2019-12-31 | $31.52 M | 139.75% |
| 2018-12-31 | $13.15 M | 54.32% |
| 2017-12-31 | $8.52 M | 14.99% |
| 2016-12-31 | $7.41 M | -0.3% |
| 2015-12-31 | $7.43 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 IBM IBM | $112.62 B | 149,084.06% | 🇺🇸 USA |
 Thomson Reuters
TRI | $7.62 B | 9,993.25% | 🇨🇦 Canada |
 Franklin Covey FC | $0.15 B | 100.15% | 🇺🇸 USA |